---
document_datetime: 2023-09-21 20:28:18
document_pages: 1
document_pathfilename: www.ema.europa.eu/en/documents/all-authorised-presentations/tasigna-epar-all-authorised-presentations_en.pdf
document_name: tasigna-epar-all-authorised-presentations_en.pdf
version: success
processing_time: 1.6607945
conversion_datetime: 2025-12-22 10:07:37.813948
docling_version:
  docling-serve: 1.9.0
  docling-jobkit: 1.8.0
  docling: 2.64.1
  docling-core: 2.55.0
  docling-ibm-models: 3.10.3
  docling-parse: 4.7.2
  python: cpython-313 (3.13.11)
  plaform: macOS-26.2-arm64-arm-64bit-Mach-O
---
| MA (EU) number   | (Invented) name   | Strength   | Pharmaceutical Form   | Route of Administration   | Immediate Packaging            | Pack size                        |
|------------------|-------------------|------------|-----------------------|---------------------------|--------------------------------|----------------------------------|
| EU/1/07/422/001  | Tasigna           | 200 mg     | Capsule, hard         | Oral use                  | Blister (PVC/PVDC/Alu); wallet | 28 capsules                      |
| EU/1/07/422/003  | Tasigna           | 200 mg     | Capsule, hard         | Oral use                  | Blister (PVC/PVDC/Alu); wallet | 112 (4x28) capsules (multipack)  |
| EU/1/07/422/005  | Tasigna           | 150 mg     | Capsule, hard         | Oral use                  | Blister (PVC/PVDC/Alu); carton | 28 capsules                      |
| EU/1/07/422/006  | Tasigna           | 150 mg     | Capsule, hard         | Oral use                  | Blister (PVC/PVDC/Alu); carton | 112 (4x28) capsules (multipack)  |
| EU/1/07/422/007  | Tasigna           | 200 mg     | Capsule, hard         | Oral use                  | Blister (PVC/PVDC/Alu);        | 28 capsules                      |
| EU/1/07/422/008  | Tasigna           | 200 mg     | Capsule, hard         | Oral use                  | Blister (PVC/PVDC/Alu); carton | 112 (4x28) capsules (multipack)  |
| EU/1/07/422/009  | Tasigna           | 150 mg     | Capsule, hard         | Oral use                  | Blister (PVC/PVDC/Alu); carton | 40 capsules                      |
| EU/1/07/422/010  | Tasigna           | 150 mg     | Capsule, hard         | Oral use                  | Blister (PVC/PVDC/Alu); carton | 120 (3x40) capsules (multipack)  |
| EU/1/07/422/011  | Tasigna           | 200 mg     | Capsule, hard         | Oral use                  | Blister (PVC/PVDC/Alu); carton | 40 capsules                      |
| EU/1/07/422/012  | Tasigna           | 200 mg     | Capsule, hard         | Oral use                  | Blister (PVC/PVDC/Alu); carton | 120 (3x40) capsules (multipack)  |
| EU/1/07/422/013  | Tasigna           | 150 mg     | Capsule, hard         | Oral use                  | Blister (PVC/PVDC/Alu); carton | 392 (14x28) capsules (multipack) |
| EU/1/07/422/014  | Tasigna           | 200 mg     | Capsule, hard         | Oral use                  | Blister (PVC/PVDC/Alu); carton | 392 (14x28) capsules (multipack) |
| EU/1/07/422/015  | Tasigna           | 50 mg      | Capsule, hard         | Oral use                  | Blister (PVC/PVDC/Alu); carton | 120 (3x40) capsules              |